Promising drug for Duchenne muscular dystrophy

Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.

This mutation leads to a severe muscle-wasting condition which leads to difficulty walking, breathing and, often by their late teens the condition is so serious, it leads to an early death.

Now researchers are working on a small drug trial with 19 children. Early results are promising and show that it may be possible to safely reduce muscle degeneration by injecting tailored pieces of antisense RNA to removed the damaged piece of the genetic code and restore dystrophin production. The new drug takes the approach of “exon skipping,” or applying a tiny molecular patch over the deletion, so that the gene can produce a shorter but still functional version of the protein.

Initial results on muscle cells cultured in a lab dish and on mice showed promise after which the drug was tried on the children aged five to 15 at hospitals in London and Newcastle. Seven out the 19 showed a “significant” response, with levels of dystrophin rising to as much as 18 percent of normal levels. The volunteers, who were treated over 12 weeks, suffered no side effects. They did not show any major improvement in a standard six-minute walking test, although this was not the goal of the mini-trial. The drug, called AVI-4658, patches exon 51, which is deleted in about 15 percent of patients with DMD.

The study published online in the Lancet reads, “On the basis of our data and recent pre-clinical data, we expect that extended administration of AVI-4658 at doses of 10 mg/kilo or higher will result in sufficient dystrophin expression to have a positive effect on the prevention of muscle degeneration.” The next step is to test it for efficacy, say the researchers, led by Francesco Muntoni of the Dubowitz Neuromuscular Centre at UCL Institute of Child Health, London.

I've worked with patients with Duchenne muscular dystrophy for many years and this is the first time we can say with confidence that we've made a significant breakthrough towards finding a targeted treatment,” said Dr. Francesco Muntoni of the University College London Institute of Child Health.

In an editorial accompanying the report, two Japanese researchers noted that the barriers to scaling up the treatment are much lower than those for gene therapy because the targeted RNA is unlikely to affect other cells in the patients' bodies. The approach might thus also be valuable for “developing treatments for other intractable hereditary neuromuscular disorders.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Promising drug for Duchenne muscular dystrophy. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20110725/Promising-drug-for-Duchenne-muscular-dystrophy.aspx.

  • MLA

    Mandal, Ananya. "Promising drug for Duchenne muscular dystrophy". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20110725/Promising-drug-for-Duchenne-muscular-dystrophy.aspx>.

  • Chicago

    Mandal, Ananya. "Promising drug for Duchenne muscular dystrophy". News-Medical. https://www.news-medical.net/news/20110725/Promising-drug-for-Duchenne-muscular-dystrophy.aspx. (accessed October 31, 2024).

  • Harvard

    Mandal, Ananya. 2018. Promising drug for Duchenne muscular dystrophy. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20110725/Promising-drug-for-Duchenne-muscular-dystrophy.aspx.

Comments

  1. Oscar Garendi Oscar Garendi Indonesia says:

    Can you help me, I have an eleven years old daughter with DMD. Is there any medicine for that. I want try for my daughter. I very frustated because DMD supposed not to infect females.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New initiative aims to train pediatricians on early mental health detection